BOPA Publication – Cancer pharmacists and consultant credentialing in Great Britain: an analysis of influencing factors and the impact of a dedicated support initiative 

Cancer pharmacists and consultant credentialing in Great Britain: an analysis of influencing factors and the impact of a dedicated support initiative 

The study explored factors influencing cancer pharmacists’ progression through consultant-level credentialing and examined the impact of the BOPA Cancer Consultant Pharmacist Credentialing Webinar Series.

The findings identified several common barriers to credentialing, including time constraints, limited organisational support and lack of mentorship. Importantly, pharmacists who attended the BOPA webinar series were more likely to report progression with their credentialing portfolio than those who did not attend.

These findings reinforce the value of providing structured support, peer networking and practical guidance to pharmacists undertaking advanced and consultant credentialing.

Read the article here:
https://academic.oup.com/ijpp/advance-article-abstract/doi/10.1093/ijpp/riag073/8704625

Continue your credentialing journey with us at our next Cancer Advanced and Consultant Pharmacist Credentialing Support Series webinar:

Date: Thursday 18 June 2026
Time: 13:00–14:00
Topic: Research Domain

Speakers:
• Nick Duncan – Consultant Pharmacist
• Dr Melanie Dalby – Clinical Academic Research Lead
• Tiffany Chan – Lead Pharmacist Cancer Services

The webinar is open to BOPA paid members who are undertaking or considering Advanced or Consultant Pharmacist credentialing.

Further information:
https://www.bopa.org.uk/credentialing-support-series/

Thank you to everyone who has contributed to and supported this important initiative.

Best wishes,

BOPA Education & Training Subcommittee

Latest News

By BOPA Executive Committee on 1st August 2026

4 Weeks left to Nominate your BOPA Fellowship

4 Weeks left to nominate a BOPA Fellow for 2026. The BOPA Fellowship Scheme Policy has been updated for a clearer nomination and selection process including specific criteria for assessing the nominated individuals.…

Read article
By BOPA Executive Committee on 31st July 2026

Supporting awareness of occupational risks from hazardous medicinal products – BOPA and PASG

Dear BOPA Member, Every day, oncology pharmacy professionals play a vital role in ensuring patients receive safe and effective SACT. Whether preparing, dispensing, transporting or supporting the administration of hazardous…

Read article
By BOPA Executive Committee on 29th July 2026

Publication ALERT – Managing aseptic capacity pressures in systemic anti-cancer therapy services: A national mixed-methods evaluation of UK SACT board guidance implementation

BOPA Publication: Managing aseptic capacity pressures in systemic anti-cancer therapy services: A national mixed-methods evaluation of UK SACT board guidance implementation – Annette (Netty) Cracknell, Dharmisha Chauhan, Lisa Barrott, Emma…

Read article
By BOPA on 24th July 2026

Call for BOPA Award nominations – 1 week left!

It’s awards time – call for nominations! We have had lots of positive feedback from the introduction of the awards dinner at the annual conference, and we are now calling…

Read article